MAPKII Kinase Inhibitor

Hsp25 Kinase Inhibitor

Catalog No. SIH-120

0 out of 5 based on 0 customer ratings
CAS No.
Molecular Formula C61H113N21O6
SKU: SIH-120 Categories: ,

Clear
Product Name MAPKII Kinase Inhibitor
Description

Hsp25 Kinase Inhibitor

Purity >95%
Molecular Formula C61H113N21O6
Molecular Weight 1396.7
Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

Properties

Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO or H20
Source Synthetic
Appearance White Solid
Safety Phrases Classification: Caution: Substance not yet fully tested.
Safety Phrases:
S22 - Do not breathe dust
S24/25 - Avoid contact with skin and eyes
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection
Cite This Product MAPKII Kinase Inhibitor (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-120)

Biological Description

Research Areas Cancer, Heat Shock
Scientific Background The MAPK (mitogen activated protein kinase) comprises a family of ubiquitous praline-directed, protein serine/threonine kinases which signal transduction pathways that control intracellular events including acute responses to hormones and major developmental changes in organisms (1). This super family consists of stress activated protein kinases (SAPKs); extracellular signal-regulated kinases (ERKs); and p38 kinases, each of which forms a separate pathway (2). In particular, MAPKAP-kinase II (or otherwise known as MK2) is involved in inflammation, and is considered a target for therapeutic intervention for inflammation and cancer (3). MK2 is a member of the p38 MAPKinase pathway, and is activated by a variety of chemical stress inducers including hydrogen peroxide, heavy metals, anisomycin, sodium salicylate, LPS, and biological stress signals such as tumor necrosis factor, interleukin-1, ionizing and UV irradiation, hyperosmotic stress and chemotherapeutic drugs (3).
References 1. Pearson G. et al. (2001). Endocrine Reviews 22 (2): 153-183.
2. Fan Y., et al. (2007) Mol. Cells 23 (1): 30-38.
3. Deng et al. (2003) Cell 115: 61-70.

Product Images

Currently there are no images for this product

Reviews

Reviews

There are no reviews yet.

Be the first to review “MAPKII Kinase Inhibitor”

Your email address will not be published. Required fields are marked *